MARSHALL WACE, LLP

Position in ABCL — AbCellera Biologics Inc.

CIK 1318757 LONDON, X0

Position in ABCL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$14,932,198

+$13,676,905 QoQ

Shares Held

1,902,191

+428.9% QoQ

Ownership

0.620%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#11

of 150 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ABCL ranks #50 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,932,198	1,902,191	+428.9%	Shares	Other	2026-08-13
2026-03-31	$1,255,293	359,683	+657.5%	Shares	Other	2026-05-15
2025-09-30	$238,824	47,480	0.0%	Shares	Other	2025-11-13
2025-06-30	$162,856	47,480	0.0%	Shares	Other	2025-08-13
2025-03-31	$105,880	47,480	-51.4%	Shares	Other	2025-05-15
2022-12-31	$988,688	97,600	-72.5%	Shares	Other	2023-02-14
2022-09-30	$3,504,986	354,397	-31.0%	Shares	Other	2022-11-14
2022-06-30	$5,471,011	513,710	+51.9%	Shares	Other	2022-08-15
2021-09-30	$6,775,924	338,120	+23.7%	Shares	Sole	2021-11-15
2021-06-30	$6,012,138	273,279	+439.6%	Shares	Sole	2021-08-13
2021-03-31	$1,719,768	50,641	-90.1%	Shares	Sole	2021-05-17
2020-12-31	$20,619,378	512,410	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.